Gavin Maggs, chief executive of Children with Cancer UK, added: “The projects we’re funding are not just advancing scientific knowledge, they have the potential to fundamentally change how these cancers are diagnosed and treated, offering children safer and more effective options than ever before.
Trending
- Work, Money, & a Normal Life
- AACR in 30 Seconds: Revolution Medicines data, NCI director, wildfires
- HDAC8 inhibition targets STAT3–MYC axis and synergizes with Venetoclax in KMT2A-rearranged acute myeloid leukemia
- Mastectomy, ET Linked to Lower LRR in Young Populations With Breast Cancer
- Revolution Medicines previews ‘novel class’ of cancer treatments
- Outlining Common Drawbacks to Prior Standards for Hodgkin Lymphoma
- CD39/PD-L1 Inhibition May Improve pCR Rate in Resectable NSCLC
- Cilta-Cel Produces Early Responses in Smoldering Multiple Myeloma
Wednesday, April 22
